Skip to main content
AVDL logo
AVDL
(NASDAQ)
Avadel Pharmaceuticals plc
$21.64-- (--)
Loading... - Market loading

Avadel Pharmaceuticals (AVDL) Balance Sheet

Assets, liabilities, and shareholders' equity with annual and quarterly data.

Avadel Pharmaceuticals Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Avadel Pharmaceuticals plc (AVDL) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017
Current Assets
Cash and Cash Equivalents51.3731.1773.9850.7171.729.779.3316.56
Short-Term Investments22.4173.9422.52106.51149.6854.3890.5977.51
Cash & Short-Term Investments73.78105.1196.50157.22221.4064.1699.9294.08
Accounts Receivable34.1012.102.2531.5438.4411.9813.9116.51
Inventory20.3010.380.000.000.003.574.776.16
Other Current Assets5.152.242.100.551.022.686.257.23
Total Current Assets134.21134.20100.84192.49263.4582.38124.85123.95
Non-Current Assets
Property, Plant & Equipment (Net)12.8613.0813.2411.498.164.167.813.00
Long-Term Investments0.000.000.000.000.000.008.751.40
Goodwill16.8416.8416.8416.8416.8418.4918.4918.49
Intangible Assets0.000.000.000.000.000.811.6392.29
Other Non-Current Assets0.340.581.871.104.9316.175.759.10
Total Non-Current Assets30.0330.5031.9454.7848.1869.0665.45128.15
Total Assets164.24164.70132.79247.27311.64151.44190.30252.11
Current Liabilities
Accounts Payable7.3311.437.897.682.936.103.507.48
Short-Term Debt1.890.7338.630.900.470.650.110.11
Current Portion of Long-Term Debt1.890.7337.670.000.000.000.000.00
Accrued Liabilities24.5411.967.378.908.680.000.000.00
Deferred Revenue0.000.000.000.000.000.000.112.01
Other Current Liabilities14.490.269.280.353.0329.2434.5976.70
Total Current Liabilities48.8336.8655.7921.0015.1135.9838.3886.18
Non-Current Liabilities
Long-Term Debt35.251.6992.39142.40128.21124.01115.730.16
Deferred Tax Liabilities0.000.000.000.000.000.000.0072.28
Other Non-Current Liabilities5.1833.015.743.924.2120.6533.4081.00
Total Non-Current Liabilities41.5540.1098.14148.02134.26144.65149.1481.37
Total Liabilities90.3976.96153.93169.02149.37180.64187.52167.54
Stockholders' Equity
Common Stock0.970.900.630.590.580.430.430.41
Retained Earnings-794.33-745.50-585.22-447.76-384.19-391.22-357.99-263.70
Accumulated Other Comprehensive Income-24.58-23.17-26.34-23.94-21.05-22.81-23.42-23.27
Additional Paid-in Capital891.79855.45589.78549.35566.92384.39383.76371.12
Shares Outstanding96.5289.8362.8858.620.000.000.000.00
Total Stockholders' Equity73.8587.74-21.1578.24162.27-29.202.7884.56
Total Liabilities & Equity164.24164.70132.79247.27311.64151.44190.30252.11

Frequently Asked Questions About Avadel Pharmaceuticals Balance Sheet

What is a balance sheet?

A balance sheet shows a company's financial position at a specific point in time. It lists total assets (what the company owns), total liabilities (what it owes), and stockholders' equity (the difference). The fundamental equation: Assets = Liabilities + Equity.

What is stockholders' equity?

Stockholders' equity represents the net value belonging to shareholders — total assets minus total liabilities. It includes retained earnings, common stock, and additional paid-in capital. Growing equity over time typically indicates a healthy, profitable business.

What is working capital?

Working capital is current assets minus current liabilities. It measures a company's ability to pay short-term obligations with short-term assets. Positive working capital indicates the company can cover its near-term debts; negative may signal liquidity risk.

What is AVDL's debt level?

Review Avadel Pharmaceuticals's total long-term debt and short-term borrowings in the balance sheet table above. Compare debt to equity and total assets to assess leverage and financial risk.

What is book value per share?

Book value per share is total stockholders' equity divided by shares outstanding. It represents the accounting value per share if the company were liquidated. Comparing market price to book value gives the price-to-book (P/B) ratio — a key valuation metric.

These financial metrics are calculated using balance sheet data. Learn how each metric works and screen stocks by them.